NORWALK, CT , Feb. 11, 2026 (GLOBE NEWSWIRE) -- HCM IV Acquisition Corp (the “Company”), a blank check company whose business purpose is to effect a merger, amalgamation, share exchange, asset ...

If you have hypertrophic cardiomyopathy (HCM) and are experiencing symptoms such as shortness of breath, chest pain, dizziness, and difficulty exercising, your doctor might suggest that you start ...

Many symptoms of hypertrophic cardiomyopathy (HCM) are mild, particularly in the early stages of the disease, so they may be easy to dismiss. Symptoms such as shortness of breath during exercise, ...

If you or a loved one has recently been diagnosed with hypertrophic cardiomyopathy (HCM), you may have questions about what it means for your health and how to manage the condition. Understanding ...

The FDA on Friday approved aficamten (Myqorzo) for symptomatic obstructive hypertrophic cardiomyopathy (HCM), drugmaker Cytokinetics announced. Aficamten is an allosteric and reversible inhibitor of ...

The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorization for Myqorzo (aficamten, Cytokinetics) for treating adults ...

ROSELAND, N.J., Dec. 9, 2025 /PRNewswire/ -- ADP, a global leader in HR and payroll solutions, today announced the finalists for the 2026 HCM Distinction Awards. Celebrating the transformation of work ...

At UKG Aspire 2025, UKG announced its Workforce Intelligence Hub, designed to consolidate workforce data across HR, pay, and workforce management, and combine it with external benchmarks and other ...

FPC is known for its expertise in payroll reconstruction, agency notice resolution, Employee Retention Credit (ERC) filings, and merger & acquisition compliance. By integrating FPC’s capabilities, HCM ...

But if you have HCM, you can make a number of lifestyle choices to protect your heart health and enjoy a high quality of life. Heavy lifting is potentially risky when you’re living with HCM, because ...

MINNEAPOLIS — Readouts of data on an experimental drug for hypertrophic cardiomyopathies showed the agent appeared safe and effective in long-term treatment and can significantly improve exercise ...

CHARLOTTE, N.C. & STAMFORD, Conn.--(BUSINESS WIRE)--HCM II Acquisition Corp. (Nasdaq: HOND) (“HCM II”), a special-purpose acquisition company and Terrestrial ...